Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–15 of 15 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT05085704
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsy, +11 more
- Locations
-
- Weill Cornell Medicine New York, United States
- UT Southwestern Medical Center Dallas, Texas, United States
A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency Syndrome
NCT07432490
- Conditions
- GLUT1DS1, Glut1 Deficiency, Glut1 Deficiency Syndrome
- Locations
-
- Oregon Health and Science University Portland, Oregon, United States
NCT02014883
- Conditions
- GLUT1 Deficiency Syndrome, Glut1 Deficiency Syndrome
- Locations
-
- Brain and Spine Institute Paris, France
Baby Detect : Genomic Newborn Screening
NCT05687474
- Conditions
- 3-Hydroxy 3-Methyl Glutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency, +368 more
- Locations
-
- CRMN, Hôpital La Citadelle Liège, Wallonia, Belgium
NCT03181399
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsy, +11 more
- Locations
-
- University of Texas Southwestern Medical Center Dallas, Texas, United States
NCT02013583
- Conditions
- GLUT-1 Deficiency Syndrome, GLUT1 Deficiency Syndrome, Glucose Transporter Type 1 Deficiency Syndrome, +2 more
- Locations
-
- UT Southwestern Medical Center Dallas, Texas, United States
NCT02915211
- Conditions
- Brain Diseases, Central Nervous System Diseases, Drug Resistant Epilepsy, +6 more
- Locations
-
- Central Manchester University Hospitals NHS Foundation Trust Manchester, Greater Manchester, United Kingdom
- Leeds Teaching Hospitals NHS Trust Leeds, West Yorkshire, United Kingdom
Evaluation of Ketoflo
NCT04399954
- Conditions
- Brain Diseases, Central Nervous System Diseases, Drug Resistant Epilepsy, +6 more
- Locations
-
- Royal Aberdeen Children's Hospital Aberdeen, United Kingdom
- Barberry Birmingham, United Kingdom
- Bristol Royal Hospital for Children Bristol, United Kingdom
- Leeds Children's Hospital Leeds, United Kingdom
NCT03041363
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsy, +11 more
- Locations
-
- UT Southwestern Medical Center Dallas, Texas, United States
NCT03722212
- Conditions
- Ataxia, Central Nervous System Diseases, De Vivo Disease, +13 more
- Locations
-
- Hôpital Larrey- CHU Angers Angers, France
- Hôpital Saint Léon Bayonne, France
- Hôpital Jean Verdier- APHP Bondy, France
- Centre hospitalier Pellegrin_ CHU Bordeaux Bordeaux, France
NCT04112862
- Conditions
- Brain Diseases, Central Nervous System Diseases, Dystonia 18, +13 more
- Locations
-
- Radboudumc Nijmegen, Gelderland, Netherlands
An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome
NCT02036853
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsy, +7 more
- Locations
-
- Cook Childrens Medical Center Fort Worth, Texas, United States
NCT01993186
- Conditions
- Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS), Glut1 Deficiency Syndrome
- Locations
-
- Children's Hospital Colorado - University of Colorado, Denver, School of Medicine Aurora, Colorado, United States
- Miami Children's Research Institute Miami, Florida, United States
- Neurology & Epilepsy Research Center Orlando, Florida, United States
- Columbia University - Department of Neurology New York, United States
NCT02018315
- Conditions
- GLUT1 Deficiency Syndrome, Glucose Transporter Type 1 Deficiency Syndrome, Glut1 Deficiency Syndrome
- Locations
-
- UT Southwestern Medical Center Dallas, Texas, United States
Early Check: Expanded Screening in Newborns
NCT03655223
- Conditions
- 17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
- Locations
-
- RTI International Research Triangle Park, North Carolina, United States